After-Hours: 2 Stocks On The Move On Another Slow Friday Afternoon

U.S. stocks tumbled on Friday trading after U.S. jobs figures missed expectations while being conceived as strong enough to leave a possible rate hike before the year on the table.

After the market closed, shares of Mylan NV MYL, which had lost 2.44 percent over the regular trading session, gained almost 9 percent, after the company reported a deal to settle on EpiPen classification rebates to Medicaid. As per a press release, the company agreed to a $465 million settlement with U.S. several government agencies, including the Department of Justice, but did not recognize any wrongdoing.

In addition, management trimmed its fiscal 2016 adjusted EPS guidance from $4.85–$5.15 to $4.70–$4.90, while assuring it remains committed to its guidance of at least $6.00 in 2018 adjusted EPS.

On the other hand, Tesla Motors Inc TSLA fell slightly (about 0.06 percent) after CEO Elon Musk tweeted “Cumulative Tesla Autopilot miles now at 222 million.”

The Vetr crowd has a 3.5-star (Buy) rating on shares of Tesla Motors. Its average price target of $209.99 implies a potential return of more than 7 percent from current valuations.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Disclosure: Javier Hasse holds no interest in any of the securities or entities mentioned above.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsGuidanceHealth CareCrowdsourcingLegalAfter-Hours CenterTechTrading IdeasGeneralElon MuskEpiPenMedicaidVetr
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!